今すぐサポートが必要ですか? 弊社は現在、新型コロナウイルスによる新しい課題に取り組むために、世界中のクライアントと協力しています。何かお手伝いできることはありますか? 詳細はこちら >

April 19, 2021 Regulatory Affairs

The Anniversary We Didn’t Want: One Year of COVID-19 Milestones

Read Blog Post
April 13, 2021 Life Science Consulting

Project Management and a Successful Reduction in Investigations Backlog: The...

Many of us have been faced with this beast that needs taming:…

Read Blog Post
April 7, 2021 Regulatory Affairs

Understanding FDA Pre-ANDA Meetings

Pre-ANDA meetings speed up the development of generics through early engagement with…

Read Blog Post
April 5, 2021 Life Science Consulting

5 Steps to CMO Identification and Selection for Cell and...

After assuring clinical validity, finding and managing the right contract manufacturing organizations…

Read Blog Post
March 24, 2021 Regulatory Affairs

The Unique Challenges of Gaining Approval for Drug-Device Combos

There are many challenges to getting a drug-device combination approved by the…

Read Blog Post
March 22, 2021 Life Science Consulting

Analytical Methods for the Investigation of Carcinogenic Nitrosamines in APIs...

Learn more about the analytical methods which can be utilised for the…

Read Blog Post
March 17, 2021 Life Science Consulting

Meet the Expert: Khaled Ahmed

ProPharma Group has launched a “Meet the Expert” series introducing you to…

Read Blog Post
March 15, 2021 Life Science Consulting

Why is Process Optimization so Important in Cell and Gene...

When applied to cell and gene therapies, process optimization is deployed as…

Read Blog Post
March 11, 2021 Regulatory Affairs

How to Manage the Risk of Elemental Impurities with ICH...

The mission of the International Council for Harmonisation of Technical Requirements for…

Read Blog Post

ビジネスには複雑な課題があります。ProPharma Groupは優れたソリューションを提供しています。

弊社は製薬企業様、バイオテクノロジー企業様、医療機器メーカー様とともに複雑な課題にチャレンジいたします。弊社の経験豊かな専門スタッフが製品ライフサイクルの全段階で薬事と開発が成功するようにお客様をサポートいたします。詳細はお問い合わせください。

業界で優位性を確保したいとお考えですか? 弊社が最新の競争力を維持するお手伝いをいたします。


すべてのフィールドが必要です。